US Inflammatory Bowel Disease (IBD) Market Size, Share & Forecast To 2019-2025


Posted August 22, 2020 by rishabh3210

US Inflammatory Bowel Disease (IBD) Market Size, Share & Forecast To 2019-2025US Inflammatory Bowel Disease (IBD) Market Size, Share & Forecast To 2019-2025

 
The US IBD market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per 100,000 population respectively in 2015. Moreover, the CDC also estimates the incidence rate of types of IBD across the country. As per the CDC, the incidence of Crohn’s disease and ulcerative colitis were nearly 14.6 and 14.3 per 100,000 population respectively in 2015. Additionally, according to the aforementioned organization, the percentage of people diagnosed with IBD (either Crohn’s disease or ulcerative colitis) increased from 0.9% of US adults in 1999 to 1.3% of US adults in 2015.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/us-ibd-inflammatory-bowel-disease-market

US IBD market is segmented on the basis of disease type, diagnostics, and therapeutics. US IBD market is segmented on the basis of disease type into ulcerative colitis and Crohn’s disease. Crohn’s disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn’s disease than ulcerative colitis. On the basis of diagnostics, the market segmented into blood and stool, endoscopies, ultrasound, and X-rays. Endoscopy is a conventional diagnostic method that is widely being used for the diagnosis of IBD and having a considerable share in the market. The therapeutics segment is further segmented into anti-inflammatory drugs and surgery.

A Full Report of US Inflammatory Bowel Disease (IBD) Market is Available at:https://www.omrglobal.com/industry-reports/us-ibd-inflammatory-bowel-disease-market

The companies which are contributing to the growth of the US IBD market include Abbott Laboratories, AbbVie Inc., Accesa Labs, Celgene Corp., Eli Lilly and Co., Johnson & Johnson Services Inc., Laboratory Corporation of America Holdings, Pfizer Inc., and others.

Market Segmentation

US IBD Market by Disease Type

Ulcerative Colitis
Crohn’s Disease

US IBD Market by Diagnostics

Blood and Stool Tests
Endoscopies,
Ultrasound
X-Ray

US IBD Market by Therapeutics

Surgery
Anti- Inflammatory Drug Administration
Steroids
Immunosuppressant
Biological Drugs
Amino salicylates
Others

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-ibd-inflammatory-bowel-disease-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Rishabh
Phone +91 780-304-0404
Country India
Categories Business
Tags US Inflammatory Bowel Disease (IBD) Market Size, Share & Forecast To 2019-2025
Last Updated August 22, 2020